Yan et al. used its targeting property to produce targeted cationic liposomes for triple-negative breast cancer treatment by silencing the Slug gene with a miRNA, a gene associated with cell invasion, metastasis, and drug resistance. This evidence concerns the gene SNAI2 and triple-negative breast carcinoma.